Hande H Tuncer (Hande Tuncer)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 6

Top Topics

Monoclonal Antibody

Chronic Lymphocytic Leukemia

Top Venues

JCO oncology practice

American journal of hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Bita Fakhri, Nnadozie Emechebe, Beenish S Manzoor, Dureshahwar Jawaid, Hasan Alhasani, Melanie Edwards, Hande H Tuncer
Real-World Health Care Resource Use and Costs Among Patients With Chronic Lymphocytic Leukemia Treated With Venetoclax-Based and Bruton Tyrosine Kinase Inhibitor-Based Regimens in the Second-Line Setting. JCO oncology practice (2024)
Bita Fakhri, Nnadozie Emechebe, Beenish S Manzoor, Dureshahwar Jawaid, Hasan Alhasani, Melanie Edwards, Hande H Tuncer
Real-World Health Care Resource Use and Costs Among Patients With Chronic Lymphocytic Leukemia Treated With Venetoclax-Based and Bruton Tyrosine Kinase Inhibitor-Based Regimens in the Second-Line Setting. JCO oncology practice 20 (8) (2024)
Bita Fakhri, Nnadozie Emechebe, Beenish S Manzoor, Dureshahwar Jawaid, Hasan Alhasani, Melanie Edwards, Hande H Tuncer
Real-World Health Care Resource Use and Costs Among Patients With Chronic Lymphocytic Leukemia Treated With Venetoclax-Based and Bruton Tyrosine Kinase Inhibitor-Based Regimens in the Second-Line Setting. JCO oncology practice 20 (8) (2024)
Bita Fakhri, Nnadozie Emechebe, Beenish S Manzoor, Dureshahwar Jawaid, Hasan Alhasani, Melanie Edwards, Hande H Tuncer
Real-World Health Care Resource Use and Costs Among Patients With Chronic Lymphocytic Leukemia Treated With Venetoclax-Based and Bruton Tyrosine Kinase Inhibitor-Based Regimens in the Second-Line Setting. JCO oncology practice (2024)
Anthony R Mato, Lindsey E Roeker, Toby Andrew Eyre, Chadi Nabhan, Nicole Lamanna, Brian T Hill, Danielle M Brander, Paul M Barr, Frederick Lansigan, Bruce D Cheson, Arun K Singavi, Maryam Sarraf Yazdy, Nirav N Shah, John N Allan, Erica B Bhavsar, Joanna Rhodes, Kaitlin Kennard, Stephen J Schuster, AnnaLynn M Williams, Alan P Skarbnik, Andre H Goy, Julie M Goodfriend, Colleen Dorsey, Catherine C Coombs, Hande H Tuncer, Chaitra S Ujjani, Ryan Jacobs, Allison M Winter, John M Pagel, Neil Bailey, Anna Schuh, Mazyar Shadman, Andrea Sitlinger, Hanna Weissbrot, Sivraj Muralikrishnan, Andrew D Zelenetz, Amy A Kirkwood, Christopher Paul Fox
A retrospective comparison of venetoclax alone or in combination with an anti-CD20 monoclonal antibody in R/R CLL. Blood advances 3 (10) (2020)
Anthony R Mato, Lindsey E Roeker, John N Allan, John M Pagel, Danielle M Brander, Brian T Hill, Bruce D Cheson, Richard R Furman, Nicole Lamanna, Constantine S Tam, Sasanka Handunnetti, Ryan Jacobs, Frederick Lansigan, Erica Bhavsar, Paul M Barr, Mazyar Shadman, Alan P Skarbnik, Andre Goy, Douglas F Beach, Jakub Svoboda, Jeffrey J Pu, Alison R Sehgal, Clive S Zent, Hande H Tuncer, Stephen J Schuster, Peter V Pickens, Nirav N Shah, Joanna Rhodes, Chaitra S Ujjani, Chadi Nabhan
Outcomes of front-line ibrutinib treated CLL patients excluded from landmark clinical trial. American journal of hematology 93 (11) (2018)